AI assistant
Sending…
Emergent BioSolutions Inc. — Director's Dealing 2015
Dec 17, 2015
32870_dirs_2015-12-17_d64de82d-d96d-41af-be0a-69ea2bee5bb8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2015-12-15
Reporting Person: Abdun-Nabi Daniel (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-15 | Common Stock | M | 4140 | $24.15 | Acquired | 188009 | Direct |
| 2015-12-15 | Common Stock | F | 2641 | $37.87 | Disposed | 185368 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-12-15 | Stock Option | $24.15 | M | 4140 | Disposed | 2018-03-14 | Common Stock (4140) | Direct |
Footnotes
F1: Consists of options granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.
F2: The option vested in three equal installments in March 2012, 2013 and 2014.
More from Emergent BioSolutions Inc.
Earnings Release
2026
Apr 30
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 30
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Board/Management Information
2026
Mar 3